● Recruiting

A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical Practice

Condition: Lung Cancer, Hepatocellular Carcinoma · Sponsor: Hoffmann-La Roche

PhaseN/A

Planned participants700

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

This is a non-interventional, multi-country, multi-centre, multicohort, primary data collection study, designed to assess patients' reported satisfaction with Atezolizumab Subcutenous (SC) treatment and Health-related Quality of Life (HRQoL), as well as the effectiveness and safety of Atezolizumab SC in participants treated for selected approved indications in routine clinical practice.

This description comes directly from the study's public registry record.

Talk to the study team

Reference Study ID Number: MO45893 https://forpatients.roche.com/ No attachments to email below. · 888-662-6728 (U.S. and Canada) · global-roche-genentech-trials@gene.com

Fastest response: use the inquiry form. https://www.gene.com/contact-us/submit-medical-inquiry

Always discuss trial participation with your own doctor first.

Locations (91)

Landesklinikum Krems	Krems, Austria	Recruiting
Ordensklinikum Linz Elisabethinen	Linz, Austria	Recruiting
Krankenhaus Nord - Klinik Floridsdorf	Vienna, Austria	Recruiting
Klinikum Wels-Grieskirchen	Wels, Austria	Recruiting
CHIREC	Auderghem, Belgium	Recruiting
AZ Sint Lucas (Sint Lucas)	Ghent, Belgium	Recruiting
CHU HELORA - Hôpital de la Louvière - Site Jolimont	Haine-Saint-Paul, Belgium	Recruiting
CHC MontLégia	Liège, Belgium	Recruiting
ZNA Jan Palfijn	Merksem, Belgium	Recruiting
CHU UCL Mont-Godinne	Mont-godinne, Belgium	Recruiting
Multiprofile Hospital for Active Treatment Uni Hospital	Panagyurishte, Bulgaria	Recruiting
Complex Oncological Center-Ruse EOOD	Rousse, Bulgaria	Recruiting

+ 79 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07284121